ANUMANA, INC.

Profile

Company Names

ANUMANA, INC.

Addresses

ONE MAIN STREET, SUITE 400, CAMBRIDGE, MA 02142

Phone Numbers

800-395-2715

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$32,000,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-11-04 
$32,000,000.00 
$32,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MURALI 
 
ARAVAMUDAN 
EXECUTIVE OFFICER, DIRECTOR
NFERENCE, INC.   |  ANUMANA, INC.
KYLE 
 
BETTIGOLE 
EXECUTIVE OFFICER
IBOSS, INC.   |  ANUMANA, INC.
ALAN 
 
COLOWICK 
DIRECTOR
NORA THERAPEUTICS, INC.   |  PRINCIPIA BIOPHARMA INC.   |  VELOSBIO INC.   |  INCARDA THERAPEUTICS, INC.   |  SOLVE THERAPEUTICS, INC.   |  RECODE THERAPEUTICS, INC.   |  ANUMANA, INC.   |  HARPOON THERAPEUTICS, INC.   |  ALUMIS INC.
HARRIS 
 
FISHMAN 
EXECUTIVE OFFICER
BIDDINGFORGOOD, INC.   |  AFFIRMED NETWORKS, INC.   |  NFERENCE, INC.   |  ANUMANA, INC.
DAVID 
 
GOEL 
DIRECTOR
MATRIX CAPITAL MANAGEMENT FUND L P   |  MATRIX CAPITAL MANAGEMENT FUND II L P   |  MATRIX ENDOWMENT FUND (OVERSEAS) LTD.   |  MATRIX CAPITAL MANAGEMENT FUND (OFFSHORE) LTD   |  MATRIX CAPITAL MANAGEMENT FUND LP   |  MATRIX CAPITAL MANAGEMENT FUND II LP   |  MATRIX CAPITAL MANAGEMENT FUND (OFFSHORE) LTD.   |  NFERENCE, INC.   |  CAMBALT SOLUTIONS, INC.   |  AYURMAYA CAPITAL MANAGEMENT FUND, LP   |  ALTPEP CORP   |  ANUMANA, INC.
CHERANJIT 
 
RIHAL 
DIRECTOR
ANUMANA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-11-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#